Document Detail


Performing clinical studies involving hernia mesh devices: what every investigator should know about the FDA investigational device exemption (IDE) process.
MedLine Citation:
PMID:  21909977     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The FDA's Center for Devices and Radiological Health (CDRH) is responsible for providing reasonable assurance of safety and effectiveness of all medical devices marketed within the US. To date, CDRH has cleared numerous hernia mesh devices for general use, but has not cleared/approved any mesh devices intended for certain specific uses, such as for infected wounds, hernia prevention, biofilm reduction, or prevention of adhesions. CDRH is requesting that manufacturers seeking specific hernia mesh device labeling claims consult with the Agency to determine the level of evidence necessary for justifying such claims.
Authors:
B S Ashar; J M Dang; D Krause; M C Luke
Related Documents :
3197947 - Development of sensitivity to maturation-inducing steroids in the oocytes of the daily ...
22189877 - Perspective: ten thousand hours to patient safety, sooner or later.
18711137 - Mosquitoes smell and avoid the insect repellent deet.
39947 - Graded imagination and relaxation as components of experimental desensitization: a psyc...
18998987 - Mymedicationlist: integrating personal medication records with resources.
6340467 - Medicolegal investigation in new york city. history and activities 1918-1978.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-11
Journal Detail:
Title:  Hernia : the journal of hernias and abdominal wall surgery     Volume:  -     ISSN:  1248-9204     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9715168     Medline TA:  Hernia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Office of Device Evaluation, Center for Devices and Radiological Health, US Food and Drug Administration, 10903 New Hampshire Avenue, WO 66, Room 422, Silver Spring, MD, 20850, USA, Binita.Ashar@fda.hhs.gov.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Specific improvement measures to reduce complications and mortality after urgent surgery in complica...
Next Document:  Advanced glycation end products and diabetic retinopathy.